New drug approvals hit 21-year high in 2017
U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.
Tuesday, January 2, 2018
New drug approvals hit 21-year high in 2017
New drug approvals hit 21-year high in 2017
U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.
Related Posts:
Jobs report gives Wall Street 'sigh of relief' as market rallies, NYSE senior market strategist says- Elon Musk slammed at Bitcoin 2021 conference following tweet, price drop
- 'Woke' corporations hit for 'bowing to China while snubbing America' as they ignore Chinese Uyghur genocide
- Facebook suspends Trump's account for 2 years, will reassess 'risk'
- JPMorgan resumes political giving, freezes out Republicans who contested 2020 election
0 comments:
Post a Comment